PMC:7212965 / 20998-21488 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T33","span":{"begin":342,"end":348},"obj":"Body_part"},{"id":"T34","span":{"begin":358,"end":363},"obj":"Body_part"},{"id":"T35","span":{"begin":468,"end":478},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"fma_id","subj":"T33","obj":"http://purl.org/sig/ont/fma/fma64183"},{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma64183"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma62852"}],"text":"n admission (5.2%). Most patients developed diarrhea during the hospitalization, which may have been attributable to other treatments or medications. In the study by Jin et al60 of 651 hospitalized patients, 8.6% of patients had diarrhea on admission before receiving any treatments. The diarrhea symptoms were described as more than 3 loose stools per day. Stool cultures were negative (including Clostridium difficile) in all patients. There was no mention of fecal leukocytes. Median dur"}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T25","span":{"begin":342,"end":348},"obj":"Body_part"},{"id":"T26","span":{"begin":358,"end":363},"obj":"Body_part"}],"attributes":[{"id":"A25","pred":"uberon_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/UBERON_0001988"},{"id":"A26","pred":"uberon_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/UBERON_0001988"}],"text":"n admission (5.2%). Most patients developed diarrhea during the hospitalization, which may have been attributable to other treatments or medications. In the study by Jin et al60 of 651 hospitalized patients, 8.6% of patients had diarrhea on admission before receiving any treatments. The diarrhea symptoms were described as more than 3 loose stools per day. Stool cultures were negative (including Clostridium difficile) in all patients. There was no mention of fecal leukocytes. Median dur"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T80","span":{"begin":44,"end":52},"obj":"Disease"},{"id":"T81","span":{"begin":229,"end":237},"obj":"Disease"},{"id":"T82","span":{"begin":288,"end":296},"obj":"Disease"},{"id":"T83","span":{"begin":336,"end":348},"obj":"Disease"}],"attributes":[{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A81","pred":"mondo_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A82","pred":"mondo_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"},{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":"n admission (5.2%). Most patients developed diarrhea during the hospitalization, which may have been attributable to other treatments or medications. In the study by Jin et al60 of 651 hospitalized patients, 8.6% of patients had diarrhea on admission before receiving any treatments. The diarrhea symptoms were described as more than 3 loose stools per day. Stool cultures were negative (including Clostridium difficile) in all patients. There was no mention of fecal leukocytes. Median dur"}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T76","span":{"begin":44,"end":52},"obj":"Phenotype"},{"id":"T77","span":{"begin":229,"end":237},"obj":"Phenotype"},{"id":"T78","span":{"begin":288,"end":296},"obj":"Phenotype"}],"attributes":[{"id":"A76","pred":"hp_id","subj":"T76","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A77","pred":"hp_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A78","pred":"hp_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/HP_0002014"}],"text":"n admission (5.2%). Most patients developed diarrhea during the hospitalization, which may have been attributable to other treatments or medications. In the study by Jin et al60 of 651 hospitalized patients, 8.6% of patients had diarrhea on admission before receiving any treatments. The diarrhea symptoms were described as more than 3 loose stools per day. Stool cultures were negative (including Clostridium difficile) in all patients. There was no mention of fecal leukocytes. Median dur"}

    2_test

    {"project":"2_test","denotations":[{"id":"32407808-32213556-43469279","span":{"begin":175,"end":177},"obj":"32213556"}],"text":"n admission (5.2%). Most patients developed diarrhea during the hospitalization, which may have been attributable to other treatments or medications. In the study by Jin et al60 of 651 hospitalized patients, 8.6% of patients had diarrhea on admission before receiving any treatments. The diarrhea symptoms were described as more than 3 loose stools per day. Stool cultures were negative (including Clostridium difficile) in all patients. There was no mention of fecal leukocytes. Median dur"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T145","span":{"begin":20,"end":149},"obj":"Sentence"},{"id":"T146","span":{"begin":150,"end":283},"obj":"Sentence"},{"id":"T147","span":{"begin":284,"end":357},"obj":"Sentence"},{"id":"T148","span":{"begin":358,"end":437},"obj":"Sentence"},{"id":"T149","span":{"begin":438,"end":479},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"n admission (5.2%). Most patients developed diarrhea during the hospitalization, which may have been attributable to other treatments or medications. In the study by Jin et al60 of 651 hospitalized patients, 8.6% of patients had diarrhea on admission before receiving any treatments. The diarrhea symptoms were described as more than 3 loose stools per day. Stool cultures were negative (including Clostridium difficile) in all patients. There was no mention of fecal leukocytes. Median dur"}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"433","span":{"begin":25,"end":33},"obj":"Species"},{"id":"434","span":{"begin":198,"end":206},"obj":"Species"},{"id":"435","span":{"begin":216,"end":224},"obj":"Species"},{"id":"436","span":{"begin":398,"end":419},"obj":"Species"},{"id":"437","span":{"begin":428,"end":436},"obj":"Species"},{"id":"444","span":{"begin":44,"end":52},"obj":"Disease"},{"id":"445","span":{"begin":229,"end":237},"obj":"Disease"},{"id":"446","span":{"begin":288,"end":305},"obj":"Disease"}],"attributes":[{"id":"A433","pred":"tao:has_database_id","subj":"433","obj":"Tax:9606"},{"id":"A434","pred":"tao:has_database_id","subj":"434","obj":"Tax:9606"},{"id":"A435","pred":"tao:has_database_id","subj":"435","obj":"Tax:9606"},{"id":"A436","pred":"tao:has_database_id","subj":"436","obj":"Tax:1496"},{"id":"A437","pred":"tao:has_database_id","subj":"437","obj":"Tax:9606"},{"id":"A444","pred":"tao:has_database_id","subj":"444","obj":"MESH:D003967"},{"id":"A445","pred":"tao:has_database_id","subj":"445","obj":"MESH:D003967"},{"id":"A446","pred":"tao:has_database_id","subj":"446","obj":"MESH:D051271"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"n admission (5.2%). Most patients developed diarrhea during the hospitalization, which may have been attributable to other treatments or medications. In the study by Jin et al60 of 651 hospitalized patients, 8.6% of patients had diarrhea on admission before receiving any treatments. The diarrhea symptoms were described as more than 3 loose stools per day. Stool cultures were negative (including Clostridium difficile) in all patients. There was no mention of fecal leukocytes. Median dur"}